ADMA Biologics
ADMA
ADMA
58 hedge funds and large institutions have $165M invested in ADMA Biologics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 5 closing their positions.
Holders
58
Holders Change
+3
Holders Change %
+5.45%
% of All Funds
1.33%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
8
Increased
23
Reduced
12
Closed
5
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K
Top Buyers
| 1 |
BC
1
Broadfin Capital
New York
|
$27.7M |
| 2 |
CCM
2
Consonance Capital Management
New York
|
$28.2M |
| 3 |
PVI
3
Pura Vida Investments
New York
|
$3.55M |
| 4 |
4
Renaissance Technologies
New York
|
$1.17M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$1.42M |
